Abstract
THE normal cellular homologue of the acutely transforming oncogene v-ra/is c-raf-l, which encodes a serine/threonine protein kinase that is activated by many extracellular stimuli1. The physiological substrates of the protein c-Raf-1 are unknown. The mitogen-activated protein (MAP) kinases ErkI and 2 are also activated by mitogens through phosphorylation of Erk tyrosine and threonine residues catalysed by a protein kinase of relative molecular mass 50,000, MAP kinase-kinase (MAPK-K)2–7. Here we report that MAPK-K as well as Erkl and 2 are constitutively active in v-raf-transformed cells. MAPK-K partially purified from v-raf-transformed cells or from mitogen-treated cells3 can be deactivated by phosphatase 2A. c-Raf-1 purified after mitogen stimulation can reactivate the phosphatase 2A-inactivated MAPK-K over 30-fold in vitro. c-Raf-1 reactivation of MAPK-K coincides with the selective phosphorylation at serine/threonine residues of a polypeptide with Mr 50,000 which coelutes precisely on cation-exchange chromatography with the MAPK-K activatable by c-Raf-1. These results indicate that c-Raf-1 is an immediate upstream activator of MAPK-K in vivo. To our knowledge, MAPK-K is the first physiological substrate of the c-raf-l protooncogene product to be identified.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rapp, U. R. Oncogene 6, 495–500 (1991).
Ahn, N. G., Weiel, J. E., Chan, C. P. & Krebs, E. G. J. biol. Chem. 265, 11487–11494 (1990).
Kyriakis, J. M., Brautigan, D. L., Ingelbritsen, T. S. & Avruch, J. J. biol. Chem. 266, 10043–10046 (1991).
Anderson, N. G., Maller, J. L., Tonks, N. K. & Sturgill, T. W. Nature 343, 651–653 (1990).
Ahn, N. G., et al. J. biol. Chem. 266, 4220–4227 (1991).
Gomez, N. & Cohen, P. Nature 353, 170–173 (1991).
Allemain, G. L., Her, J.-H., Wu, J., Sturgill, T. W. & Weber, M. J. Molec. cell. Biol. 12, 2222–2229 (1992).
Rapp, U. R., Reynolds, F. H. & Stephenson, J. R. J. Virol. 45, 914–924 (1983).
Matsuda, S. et al. EMBO J. 11, 973–982 (1992).
Pulverer, B. J., et al. Nature 353, 670–674 (1991).
Sturgill, T. W., Ray, L. B., Erikson, E. & Maller, J. L. Nature 334, 715–718 (1988).
Dent, P. et al. Nature 348, 302–308 (1990).
Anderson, N. G. et al. Biochem. J. 277, 573–576 (1991).
Lee, R.-M., Cobb, M. H. & Blackshear, P. J. J. biol. Chem. 267, 1088–1092 (1992).
Downward, J. et al. Nature 346, 719–723 (1990).
Burgering, B. M. et al. EMBO J. 10, 1103–1109 (1991).
Satoh, T., Nakafuku, M., Miyajima, A. & Kaziro, Y. Proc natn. Acad. Sci. U.S.A. 88, 3314–3318 (1991).
Leevers, S. J. & Marshall, C. J. EMBO J. 11, 569–574 (1992).
Bruder, J. T., Heidecker, G. & Rapp, U. R. Genes Dev. 6, 545–556 (1992).
Troppmair, J. et al. Oncogene (in the press).
Grove, J. R., Price, D. J., Goodman, H. M. & Avruch, J. Science 238, 530–533 (1987).
Hsi, E. D. et al. J. Biol. Chem. 264, 10836–10842 (1989).
Kyriakis, J. M. & Avruch, J. J. biol. Chem. 265, 17355–17363 (1990).
Takeda, M. et al. J. biol. Chem. 258, 10455–10463 (1988).
Jones, S. W., Erikson, R. L., Ingebritsen, V. M. & Ingebritsen, T. S. J. biol. Chem. 264, 7747–7753 (1989).
Kyriakis, J. M. & Avruch, J. Biochem. Biophys. Acta 1054, 73–82 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kyriakis, J., App, H., Zhang, Xf. et al. Raf-1 activates MAP kinase-kinase. Nature 358, 417–421 (1992). https://doi.org/10.1038/358417a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/358417a0